Innospec Statistics
Total Valuation
Innospec has a market cap or net worth of $2.11 billion. The enterprise value is $1.85 billion.
| Market Cap | 2.11B |
| Enterprise Value | 1.85B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | May 20, 2025 |
Share Statistics
Innospec has 24.96 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 24.96M |
| Shares Outstanding | 24.96M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 1.17% |
| Owned by Institutions (%) | 97.24% |
| Float | 24.65M |
Valuation Ratios
The trailing PE ratio is 76.54 and the forward PE ratio is 14.67. Innospec's PEG ratio is 1.96.
| PE Ratio | 76.54 |
| Forward PE | 14.67 |
| PS Ratio | 1.16 |
| Forward PS | 1.11 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | 22.67 |
| P/OCF Ratio | 15.96 |
| PEG Ratio | 1.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.93, with an EV/FCF ratio of 19.92.
| EV / Earnings | 68.69 |
| EV / Sales | 1.04 |
| EV / EBITDA | 27.93 |
| EV / EBIT | 81.35 |
| EV / FCF | 19.92 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.73 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.48 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 2.20% and return on invested capital (ROIC) is 1.12%.
| Return on Equity (ROE) | 2.20% |
| Return on Assets (ROA) | 0.81% |
| Return on Invested Capital (ROIC) | 1.12% |
| Return on Capital Employed (ROCE) | 1.61% |
| Revenue Per Employee | $728,980 |
| Profits Per Employee | $11,020 |
| Employee Count | 2,450 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, Innospec has paid $3.30 million in taxes.
| Income Tax | 3.30M |
| Effective Tax Rate | 10.89% |
Stock Price Statistics
The stock price has decreased by -31.55% in the last 52 weeks. The beta is 1.05, so Innospec's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -31.55% |
| 50-Day Moving Average | 87.44 |
| 200-Day Moving Average | 103.40 |
| Relative Strength Index (RSI) | 43.55 |
| Average Volume (20 Days) | 240,032 |
Short Selling Information
The latest short interest is 183,165, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 183,165 |
| Short Previous Month | 253,894 |
| Short % of Shares Out | 0.73% |
| Short % of Float | 0.74% |
| Short Ratio (days to cover) | 0.97 |
Income Statement
In the last 12 months, Innospec had revenue of $1.79 billion and earned $27.00 million in profits. Earnings per share was $1.08.
| Revenue | 1.79B |
| Gross Profit | 512.30M |
| Operating Income | 22.80M |
| Pretax Income | 191.80M |
| Net Income | 27.00M |
| EBITDA | 66.40M |
| EBIT | 22.80M |
| Earnings Per Share (EPS) | $1.08 |
Balance Sheet
The company has $299.80 million in cash and $44.40 million in debt, giving a net cash position of $255.40 million or $10.23 per share.
| Cash & Cash Equivalents | 299.80M |
| Total Debt | 44.40M |
| Net Cash | 255.40M |
| Net Cash Per Share | $10.23 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 50.45 |
| Working Capital | 619.50M |
Cash Flow
In the last 12 months, operating cash flow was $132.20 million and capital expenditures -$39.10 million, giving a free cash flow of $93.10 million.
| Operating Cash Flow | 132.20M |
| Capital Expenditures | -39.10M |
| Free Cash Flow | 93.10M |
| FCF Per Share | $3.73 |
Margins
Gross margin is 28.68%, with operating and profit margins of 1.28% and 1.51%.
| Gross Margin | 28.68% |
| Operating Margin | 1.28% |
| Pretax Margin | 1.70% |
| Profit Margin | 1.51% |
| EBITDA Margin | 3.72% |
| EBIT Margin | 1.28% |
| FCF Margin | 5.21% |
Dividends & Yields
This stock pays an annual dividend of $1.58, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | $1.58 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | 10.14% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 150.63% |
| Buyback Yield | -0.32% |
| Shareholder Yield | 1.55% |
| Earnings Yield | 1.28% |
| FCF Yield | 4.41% |
Analyst Forecast
The average price target for Innospec is $155.00, which is 83.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $155.00 |
| Price Target Difference | 83.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 23, 2007. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 23, 2007 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Innospec has an Altman Z-Score of 5.7 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 5 |